Cited by 847Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Gardner, Christopher D.·1996·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1996.03540110029028

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To investigate the prospective association of low-density lipoprotein (LDL) particle diameter with the incidence of fatal and nonfatal coronary artery disease (CAD). DESIGN: A nested case-control study. SETTING: Cases and controls were identified from a population-based sample of men and women combining all of the 5 cross-sectional surveys conducted from 1979 to 1990 of the Stanford Five-City Project (FCP). PARTICIPANTS: Incident CAD cases were identified through FCP surveillance between 1979 and 1992. Controls were matched by sex, 5-year age groups, survey time point, ethnicity, and FCP treatment condition. The sample included 124 matched pairs: 90 pairs of men and 34 pairs of women. MAIN OUTCOME MEASURES: LDL peak particle diameter (LDL size) was determined by gradient gel electrophoresis on plasma samples collected during the cross-sectional surveys (stored at 70 degrees C for 5-15 years). Established CAD risk-factor data were available from FCP baseline measurements. RESULTS: LDL size was smaller among CAD cases than controls (mean +/- SD) (26.17 +/- 1.00 nm vs 26.68 +/- 0.90 nm; P<.001). The association was graded across control quintiles of LDL size. The significant case-control difference in LDL size was independent of levels of high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C), triglyceride, smoking, systolic blood pressure, and body mass index, but was not significant after adjusting for the ratio of total cholesterol (TC) to HDL-C (TC:HDL-C). Among all the physiological risk factors, LDL size was the best differentiator of CAD status in conditional logistic regression. However, when added to the physiological parameters above, the TC:HDL-C ratio was found to be a stronger independent predictor of CAD status. CONCLUSION: LDL size was significantly smaller in CAD cases than in controls in a prospective, population-based study. These findings support other evidence of a role for small, dense LDL particles in the etiology of atherosclerosis.

Integrity signals

Registry

Crossref · 10.1001/jama.1996.03540110029028

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G. C., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K. A., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. F. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,339
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 908
NHLBI funding policies. Enhancing stability, predictability, and cost control.
Lenfant, C. L. (1994) · Circulation · doi:10.1161/01.cir.90.1.1 · Cited by 763
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
Graaf, J. D., Hak-Lemmers, H. L. M., Hectors, M. P. C., Demacker, P. N. M., Hendriks, J. C. M., & Stalenhoef, A. F. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
Reaven, G. M., Chen, Y. I., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 687
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
Chait, A., Brazg, R., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554

Show all 53 references

Sorted by citations

Items 701–800 of 847

Association of lipids with coronary heart disease in a saudi population
Ashmaig, M., Ashmeik, K., Ahmed, A. A., Sobki, S. H., & Abdulla, M. (2011) · Jornal Vascular Brasileiro · doi:10.1590/s1677-54492011000200007 · Cited by 3
Clinical trials and clinical practice ‐ bridging the gaps in type 2 diabetes. An evidence‐based approach to risk factor modification in type 2 diabetes
Greenfield, J. R., & Chisholm, D. J. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb02056.x · Cited by 3
Rosiglitazone and Fenofibrate Additive Effects on Lipids
Slim, A. M., Castillo-Rojas, L. M., Hulten, E., Slim, J. N., Pearce-Moore, D., & Villines, T. C. (2011) · Cholesterol · doi:10.1155/2011/286875 · Cited by 3
“Three distinct peroxisome proliferator-activated receptors (PPARs), termed alpha, beta, and gamma, modulate intracellular lipid and glucose metabolism through controlling gene expression when activated [7].”
Background
Reducing cardiovascular risk in patients with type 2 diabetes: the potential contribution of nicotinic acid
van Gaal, L. V., Peiffer, F., & Ballaux, D. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050060901 · Cited by 5
Vascular Dysfunction in Heart Disease
Perrault, R., & Zahradka, P. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7130-2_21 · Cited by 3
“In fact, an even greater correlation was found between oxLDL and CVD than was found with hypercholesterolemia [21].”
Background
Low density lipoprotein particle size phenotyping in healthy persons and patients with myocardial infarction.
Alabakovska, S. B., Labudović, D. D., Tosheska, K. N., & Todorova, B. (2002) · PubMed · Cited by 3
Lipid profile in normal pregnancy
Garabet, S. (2012) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2012.0034 · Cited by 3
Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography
Masuda, D., Kiyosue, A., Hirayama, A., Shimauchi, J., López, J. A. G., Miyawaki, K., & Yamashita, S. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.54353 · Cited by 3
Nuevas recomendaciones del National Cholesterol Education Program (NCEP). Consecuencias en el laboratorio clínico
Zapico, E., & Ordóñez‐Llanos, J. (2002) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(02)78872-4 · Cited by 3
“Estas partículas han de-mostrado tener un alto poder aterogénico 10,11 .”
Management of dyslipidemias in the age of statins
Green, M. L. (2003) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(03)00095-2 · Cited by 3
An Organizational Model to Translate Nutritional Recommendations into Routine Clinical Practice in Secondary Prevention of Coronary Artery Disease
Aquilani, R., Boni, S., Verdirosi, S., Pastoris, O., Assandri, J., Rossi, A., Paganini, V., Riccardi, R., Cajelli, A., Pernice, M., et al. (2002) · Preventive Medicine · doi:10.1006/pmed.2001.0958 · Cited by 3
Assessment and Management of Lipid Disorders in Men
Haines, C. A., Collins, L. G., & Nimoityn, P. (2006) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2005.11.008 · Cited by 3
“Patients with metabolic syndrome Metabolic syndrome, characterized by insulin resistance, high triglycerides, low HDL cholesterol, and elevated LDL cholesterol, has been associated with an increased risk of CHD [45,46].”
Background
Preventive Cardiology: The Effects of Exercise
Khera, A., Mitchell, J. H., & Levine, B. D. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_129 · Cited by 2
Hipertensión arterial y dislipemia asociadas a diabetes mellitus. Papel de los PPAR. Enfoque terapéutico
Bertomeu‐González, V., Pernas, D. N., & Bertoméu, V. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75270-6 · Cited by 1
Triglyceride metabolism in Japanese kidney transplant recipients
Tsujita, M., Goto, N., Futamura, K., Okada, M., Hiramitsu, T., Narumi, S., & Watarai, Y. (2017) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1462-1 · Cited by 2
“Postprandial hypertriglyceridemia has also been established as an important risk factor for CVD.”
BackgroundInfluential
Preventive Cardiology: The Effects of Exercise
Schopfer, D. W., Khera, A., Levine, B. D., & Forman, D. E. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_28 · Cited by 2
MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy
Tian, Y., Wang, J., Liu, Y., Luo, X., Yao, Z., Wang, X., Zhang, Y., Xu, C., & Zhao, X. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00937-8 · Cited by 2
Egg composition vs CVD risk: from lipid to endothelial and inflammatory hypotheses.
Shapira, N., Meester, F. D., & WATSON, R. R. (2008) · Cited by 2
Diet, the Control of Blood Lipids, and the Prevention of Heart Disease
Flock, M. R., & Kris‐Etherton, P. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-894-8_9 · Cited by 3
HDL, apo B/apo A1 ratio, Diabetes Mellitus and Cardiovascular Disease
Sultan, D., Sachu, P., & Elshaari, F. A. (2013) · InTech eBooks · doi:10.5772/56476 · Cited by 2
“…CETP and hepatic lipase activity, observed in insulin resistant and type 2diabetes subjects, favor the formation of sdLDL (Bagdade et al., 1993 and Riemens et al., 1998)A predominance of small, dense LDL particles is associated with increased risk of CHD (Austin et al., 1988, Gardner et al., 1996).”
Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage
Narayanan, S. (1999) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02867909 · Cited by 2
Low Density Lipoprotein-Heterogenität als prognostischer Marker kardiovaskulärer Erkrankungen / Low density lipoprotein heterogeneity for risk evaluation of cardiovascular disease
Winkler, K. (2004) · Journal of Laboratory Medicine · doi:10.1515/labmed.2004.060 · Cited by 2
The Lipid Management Nutrition Outcomes Project: Perspectives from a National Experience in Protocol Implementation and Nutrition Outcomes Tracking
Rhodes, K. S., Weintraub, M. S., Biesemeier, C. K., & Rubenfire, M. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.10.048 · Cited by 2
A Higher Burden of Small Low-density Lipoprotein Particles is Associated with Profound Changes in the Free Androgen Index in Male Adolescents
Choi, Y. J., Choi, S. H., Kim, H. J., Han, S. J., Hwang, J. S., Chung, Y., Lee, K. W., Cho, H. K., & Kim, D. J. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.4.534 · Cited by 2
“Studies have shown that sd-LDL has greater atherogenic potential than lb-LDL in various ethnic groups (6-9).”
Background
The Assessment of the Atherogenic Lipoprotein Profile in Cardiovascular Diseases by Lipoprint System Analysis
Oravec, S., Gruber, K., Dukát, A., Gavorník, P., Gašpar, Ľ., & Dostal, E. (2015) · InTech eBooks · doi:10.5772/60989 · Cited by 4
“Hypercholes‐ terolemia and hypertriglyceridemia, as well as combined hyperlipoproteinemia are regular features that accompany CHD [22,50,51].”
BackgroundInfluential
Common uses of multivariable models
Katz, M. H. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511811692.003 · Cited by 2
Lipoproteins and Apoproteins
Citkowitz, E., & Herbert, P. N. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_3 · Cited by 2
Egg Composition vs CVD Risk
Shapira, N. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-330-1_12 · Cited by 2
“Several studies have reported a two- to three-fold increase in CHD risk among patients with high SD-LDL (30,33, 34 ).”
Background
Pathophysiology and clinical significance of atherogenic lipoprotein phenotype and small dense LDL particles
Djerić, M. (2003) · Jugoslovenska medicinska biohemija · doi:10.2298/jmh0302101d · Cited by 2
Emerging Biomarkers of Instability
Tsimikas, S. (2006) · Wiley eBooks · doi:10.1002/9780470987575.ch11 · Cited by 2
Nutritional Management for Type 2 Diabetes
Coulston, A. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012193155-1/50031-3 · Cited by 2
CURRENT AND FUTURE TRENDS IN THERAPY FOR DYSLIPIDEMIAS
Superko, H. R. (1997) · Endocrine Practice · doi:10.4158/3.4.255 · Cited by 2
The Insulin Resistance Syndrome
Yki‐Järvinen, H. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0410 · Cited by 2
GENETIC SUSCEPTIBILITY TO THE METABOLIC SYNDROME
Bossé, Y. (2004) · Corpus Université Laval (Université Laval) · Cited by 2
Oxidized Low-Density Lipoprotein (Ox-LDL) and Malondialdehyde (MDA) and Menopause: Loss of Protective Effect of Premenopuasl Status in Type 2 Diabetes MellitusPreprint
Arani, R. H., Rabizadeh, S., Rajab, A., Heidari, F., Esteghamati, A., Mirmiranpour, H., Hajmiri, M. S., & Nakhjavani, M. (2020) · doi:10.21203/rs.3.rs-37984/v1 · Cited by 2
“Ox-LDL particles play an active role in developing endothelial dysfunction and atherosclerotic disease [2-6].”
Background
Combined Effects of Ambient PM2.5 and Cold Exposure on the Development of Metabolic Disorder
Liu, Z., Zhang, J., Fan, D., Wang, G., Wu, B., Lei, L., Wang, L., Zhao, J., & Chen, J. (2023) · Atmosphere · doi:10.3390/atmos14071157 · Cited by 2
Unmet Cardiovascular Risk Beyond LDL-C: A Perspective on Managing Residual Cardiovascular Risk
Kypreos, K. E., Gafencu, A. V., Andreopoulou, O., Zvintzou, E., Marinos, K., Mparnia, V., Alemi, M., Daraban, B. S., Multescu, M. G., Ghinea, M., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19071071 · Cited by 2
“Even at physiologic triglyceride concentrations, elevated numbers of small, dense APOB-containing particles may substantially contribute to residual cardiovascular risk [30].”
Advanced Lipid Testing
Sorrentino, M. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-502-6_5 · Cited by 1
Heterogeneidad de las subfracciones de las lipoproteínas de baja densidad
Jorba, O. J., & Ordóñez‐Llanos, J. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73650-6 · Cited by 1
Lipoprotein metabolism abnormalities in patients with chronic renal insufficiency
Jugovic, M., Spasojević‐Kalimanovska, V., Spasić, S., & Nikolić, Z. (2002) · Jugoslovenska medicinska biohemija · doi:10.2298/jmh0204323j · Cited by 1
Primary disorders of LDL-cholesterol metabolism
Rosenson, R. S., de Ferranti, S. D., Freeman, M. W., & Saperia, G. M. (2011) · Cited by 1
Role of Polyunsaturated Fatty Acids in Cardiovascular Diseases
Asif, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Change of HDL in Various Diseases
Cho, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-7387-9_3 · Cited by 1
Change of HDL by Life Style
Cho, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-7387-9_2 · Cited by 1
Elevated sdLDL level and LDLR rs688 C>T mutation are independent risk factors for ischemic stroke
Chen, Y., Cai, H., Zhang, J., Su, Y., Wu, Y., Lin, Z., & Zhang, Z. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.10.006 · Cited by 1
Lipids and Bariatric Surgery
Schewe, T., & Winkler, K. (2012) · Springer eBooks · doi:10.1007/978-3-642-02411-5_8 · Cited by 1
The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
Sharma, S. T., & Nestler, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_10 · Cited by 1
“Small, dense LDL particles have been linked with a 3- to 7-fold increased relative risk of CAD [ 50 ].”
Background
Phospholipase A2 in the pathogenesis of cardiovascular disease
Hurt‐Camejo, E., Sartipy, P., Peilot, H., Rosengren, B. E., Wiklund, O., & Camejo, G. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)12010-x · Cited by 1
The Effect of Quail Egg and Hen Egg Consumption on Low-Density Lipoprotein Oxidation and Small Dense Low-Density Lipoprotein
Mingpakanee, R., Chaisitthichai, C., Wichitamporn, N., Sappittayakorn, P., & Phongphanwatana, S. (2019) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.201946 · Cited by 1
High low‐density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions
Hasegawa, S., Nakano, T., Mukai, Y., Matsukuma, Y., Yotsueda, R., Tsuchimoto, A., Fujisaki, K., Tsuruya, K., Tsutsui, H., & Kitazono, T. (2020) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13558 · Cited by 1
Common uses of multivariable models
Katz, M. H. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974175.003 · Cited by 1
Risk Factors and Beliefs About Cardiovascular Disease Among Active Duty Service Members
Prue-Owens, K. (2007) · UA Campus Repository (The University of Arizona) · Cited by 1
Besonderheiten im atherogenen Risikoprofil der KHK bei Frauen
Winkler, K. E., März, W., Baumstark, M. W., & Berg, A. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57534-1_5 · Cited by 1
Lipoprotein-associated phospholipase A2 (Lp-PLA2) Impact and role as cardiovascular risk marker
Persson, M. (2008) · Lund University Publications (Lund University) · Cited by 1
Detection of small dense LDL-cholesterol: is it necessary to determine particle size?
Wierzbicki, A. S. (2008) · Future Lipidology · doi:10.2217/17460875.3.1.23 · Cited by 1
“3 mmol/l was chosen [10], paralleling the data from the Munster Heart Study (PROCAM) [3].”
Method
Hormonal Regulation of Lipid Metabolism in Healthy Subjects with or without Obesity
Соколова, Е. Ю., & Nv, P. (2004) · Human Physiology · doi:10.1023/b:hump.0000036339.26918.92 · Cited by 1
Atherosclerotic disease in non–insulin-dependent diabetes mellitus: Role of abnormal lipids and the place for lipid-altering therapies
Orloff, D. G., Blazing, M. A., & O’Connor, C. M. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70043-8 · Cited by 1
Hypertriglyceridemia and atherogenic lipoprotein phenotype: Triglycerides and atherosclerosis
Djerić, M. (2002) · Medicinski pregled · doi:10.2298/mpns0204085d · Cited by 1
SIALIC ACID IN LIPOPROTEINS WITH A SPECIAL REFERENCE TO LOW DENSITY LIPOPROTEINS
Lindbohm, N. (2000) · Työväentutkimus Vuosikirja · Cited by 1
Polycystic ovary syndrome and associated metabolic features in indigenous women in the Northern Territory.
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Women and cardiovascular heart disease
Kuller, L. H. (2005) · doi:10.1093/acprof:oso/9780198525738.003.0023 · Cited by 1
The Role of Chlamydia pneumoniae-induced Platelet Activation in Cardiovascular Disease : In vitro and In vivo studies
Kälvegren, H. (2007) · DiVA (Linkoping University) · Cited by 1
The effect of prior exercise on postprandial lipaemia
Hurren, N. M. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
Lipids and Lipoproteins and Effects of Hormone Therapy
Krauss, R. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50041-7
Stroke and coronary heart disease in relation to hyperglycemia gender and age
Hyvärinen, M. (2009) · Työväentutkimus Vuosikirja
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Studies of Atherogenic Lipoproteins Using Mass Spectrometry-Based Lipidomics
Ståhlman, M. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
A study of omega-3 fatty acid therapy in patients with nephrotic syndrome
Siddiqui, S. (2008) · Enlighten: Theses (The University of Glasgow)
Estrés oxidativo y fibrogénesis en la diabetes mellitus tipo 1: Influencia del control glucémico y del consumo de tabaco.
Meneses, L. F. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Hormonersatztherapie und das kardiovaskuläre Risiko der postmenopausalen Frau
Eidenmüller, B. (2007)
Estrés quirúrgico durante el bypass gástrico en obesos mórbidos
Déniz, J. R. (2010) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Comparison of coronary heart disease risk factors in foreign-born and United States-born Afro Caribbean Americans and African Americans in South Florida
Davis, E. (2004) · doi:10.25148/etd.fi14062211
Metabolic Stress and Atherosclerosis
Reusch, J. E. B., & Brownlee, M. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1011
Coronary Heart Disease, Lipid Metabolism, and Steroid Hormones in Women
Evans, R. G. (2000) · Elsevier eBooks · doi:10.1016/b978-012288145-9/50076-0
Association Between Fatty Liver and Cardiovascular Disease: Mechanism and Clinical Implications
Nseir, W., & Assy, N. (2011) · InTech eBooks · doi:10.5772/21294 · Cited by 1
“The presence of small dense LDL particles is associated with increased CVD risk [102].”
Background
Lipide und Diabetes
Riedl, M., & Clodi, M. (2002) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Fenofibrat v lechenii aterogennykh dislipoproteidemiy i ateroskleroza
Perova, N. V. (2007) · Obesity and metabolism · doi:10.14341/2071-8713-5015
Small Dense Low-density Lipoprotein and Cardiovascular Disease
Suh, S., & Lee, M. (2012) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2012.1.1.1
A Dietary Supplement with a High Eicosapentaenoic Acid to Docosahexaenoic Acid Ratio Reduces Triglyceride Levels in Mildly Hypertriglyceridemic Subjects
Ryan, A. S., Porter, S. S., & Sancilio, F. D. (2013) · Food and Nutrition Sciences · doi:10.4236/fns.2013.41002 · Cited by 1
“Although fish oils containing both EPA and DHA can increase LDL-C levels the increase is associated with a shift in lipoprotein particle size from the small, atherogenic to the larger more buoyant and less atherogenic particle size(s) [15,16].”
Background
Is There Evidence for the Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women?
Roberts, B. H., & Thompson, P. D. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80189-0
Seeing the forest through the trees: big trucks—little trucks
Dayspring, T. D. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200203000-00001
Impacto del metabolismo lipídico en la aterogénesis femenina
García-Martínez, M. C., Cano, A., & Hermenegildo, C. (2001) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(01)75617-8
Sophisticated Tests for Susceptibility to Atherosclerosis:An Added Value for Heart Hospitals
Superko, H. R. (2003) · The American Heart Hospital Journal · doi:10.1111/j.1541-9215.2003.02362.x
Factores de riesgo cardiovascular y tratamiento hipolipemiante en la enfermedad cerebrovascular, cardíaca y periférica
Georgieva, R. I. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Chronic diabetic complications in clinically, immunologically and genetically defined subgroups
Isomaa, B. (2001) · Työväentutkimus Vuosikirja
The involvement of INSIGs, DGAT1 and APOB in human lipid metabolism
Krapivner, S. (2008) · Figshare
--Random Thoughts and Opinions
Kreisberg, R. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2110
Façons d’identifier et de prendre en charge la dyslipidémie athérogène
Bosomworth, N. J. (2013) · Europe PMC (PubMed Central)
Étude des mécanismes athérogènes associés à l'insulino-résistance et l'hypercholestérolémie familiale
Hogue, J. (2008) · Corpus Université Laval (Université Laval)
LIPOPROTEIN METABOLISM ABNORMALITIES IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY ABNORMALNOSTI U METABOLIZMU LIPOPROTEINA KOD PACIJENATA SA HRONI^NOM BUBRE@NOM INSUFICIJENCIJOM
Ali, A. A., Sultan, P., El-Napoli, M., & Fahmy, M. A. H. (2011)
A follow-up study of serum cholesterol and lipoproteins in children : The effect of diet and apolipoprotein E on cholesterol metabolism, tracking, and screening
KALLIO, M. J. T. (2001) · Työväentutkimus Vuosikirja
Razão triglicerídios / HDL-colesterol como preditor do perfil de subclasses de lipoproteínas
Toé, D., & Fernandes, T. (2007) · Americanae (AECID Library)
What are probiotics?
Kuvatanasuchati, J. (2007) · Chulalongkorn University Dental Journal · doi:10.58837/chula.cudj.30.2.10
The Newer Coronary Risk Factors
Wilson, P. W. F. (2003) · doi:10.1007/978-1-4615-6484-3_10
im atherogenen Risikoprofil der KHK bei Frauen
Winkler, K. E., März, W., Baumstark, M. W., & Berg, A. (2002)
Façons d’identifier et de prendre en charge la dyslipidémie athérogène
Bosomworth, N. J. (2013) · Canadian Family Physician
The Fats of Life
Koba, S., Yokota, Y., Ito, Y., Hirano, T., & McConnell, J. P. (2009)
Diabetes and Cardiovascular Disease
Gore, M. O., Inzucchi, S. E., & McGuire, D. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00021-4
New Insights on the Role of Lipids and Lipoproteins in Cardiovascular Disease
Psota, T., Hilpert, K. F., Gebauer, S. K., Kris‐Etherton, P. M., Griel, A. E., & Coa, Y. (2005) · CRC Press eBooks · doi:10.1201/9781420038422.ch11
Metabolic Syndrome: Overview and Relationship with Psychiatric Disorders
Bermudes, R. A., & Guerdjikova, A. I. (2006) · CRC Press eBooks · doi:10.3109/9780849374517.008 · Cited by 1

Authors: Gardner, C. D.
Affiliations: Stanford Medicine (US)
Corresponding author: Gardner, Christopher D.
ORCID: Gardner, Christopher D.
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1996-09-18
Volume: 276
Issue: 11
Pages: 875
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1996.03540110029028
OpenAlex: W2050758709
Cited by: 843
References: 53
Citations by year: 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 10 · 2021: 16 · 2020: 23 · 2019: 14 · 2018: 7 · 2017: 16 · 2016: 10 · 2015: 23 · 2014: 14 · 2013: 33 · 2012: 22
FWCI: 37.88
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p01hl018574-26, 5r01hl021906-19)
National Heart, Lung, and Blood Institute (T32HL007034, HL21906, HL-18574, 5 T32 HL07034)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: small dense LDL, LDL particle size, coronary artery disease, atherosclerosis, cardiovascular risk factors, TC/HDL-C ratio, HDL cholesterol, non-HDL cholesterol, triglycerides, sex differences
MeSH terms: Adult, Aged, Coronary Disease, Cross-Sectional Studies, Electrophoresis, Polyacrylamide Gel, Female, Humans, Lipids, Lipoproteins, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Body Mass Index, Incidence, Linear Models, Logistic Models, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks